CNBC April 17, 2025
Ashley Capoot

Key Points

– The House Committee on Energy and Commerce sent a letter to 23andMe expressing concern that its genetic data is “at risk of being compromised.”

– The embattled genetic testing company filed for Chapter 11 bankruptcy protection in March, and its assets are up for sale.

– The congressmen said there are reports that some users have had trouble deleting their data from the company’s site.

The House Committee on Energy and Commerce is investigating 23andMe‘s decision to file for Chapter 11 bankruptcy protection and has expressed concern that its sensitive genetic data is “at risk of being compromised,” CNBC has learned.

Rep. Brett Guthrie, R-Ky., Rep. Gus Bilirakis, R-Fla., and Rep. Gary Palmer, R.-Ala., sent a letter...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Congress / White House, Govt Agencies, Pharma / Biotech, Precision Medicine
JPM 2026: Genoa Ventures’ Jenny Rooke on Next-Gen Clinical Assessment Tools
From Early Detection to Targeted Therapy: How AI is Reframing Precision Medicine
How Precision Medicine and AI are Evolving: An MD Anderson Perspective
Bringing Precision Medicine Into the Home
Inside the Virtual Cell: New Depths for Precision Medicine

Share Article